Literature DB >> 24874051

MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R.

Xiaoli Wang1, Yuchang Wang, Hongwen Lan, Jun Li.   

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs which act as oncogenes or tumor suppressors in multiple human cancers. Accumulating evidence reveals that aberrant expression of miRNAs contributes to the development and progression of non-small cell lung cancer (NSCLC). Here, we identified miR-195 as a tumor suppressor in NSCLC cells, whose expression level was dramatically decreased in both NSCLC tissues and cell lines. Ectopic expression of miR-195 suppressed NSCLC cell proliferation and metastasis-related traits in vitro. Insulin-like growth factor 1 receptor (IGF1R) was identified as a direct target of miR-195 in NSCLC cells. Furthermore, restoration of IGF1R remarkably attenuated the tumor suppressive effects of miR-195 on NSCLC cells. Our data suggest that miR-195 may be involved in the carcinogenesis of NSCLC partially by targeting IGF1R.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24874051     DOI: 10.1007/s13277-014-2140-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

1.  MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.

Authors:  Yi Zhang; Qiping Lu; Xun Cai
Journal:  FEBS Lett       Date:  2013-08-08       Impact factor: 4.124

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

3.  Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.

Authors:  Yang Ke; Weiyong Zhao; Jie Xiong; Rubo Cao
Journal:  FEBS Lett       Date:  2013-08-13       Impact factor: 4.124

4.  Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β-cell functions, and β-cell proliferation in male mice.

Authors:  Jun Shirakawa; Tomoko Okuyama; Eiko Yoshida; Mari Shimizu; Yuka Horigome; Takayuki Tuno; Moe Hayasaka; Shiori Abe; Masahiro Fuse; Yu Togashi; Yasuo Terauchi
Journal:  Endocrinology       Date:  2014-04-08       Impact factor: 4.736

5.  miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.

Authors:  Haifeng Yang; Qi Li; Wohua Zhao; Dun Yuan; Hongyang Zhao; Yong Zhou
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

6.  MiR-25 promotes gastric cancer cells growth and motility by targeting RECK.

Authors:  Hongying Zhao; Yu Wang; Liu Yang; Rongke Jiang; Wenqing Li
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

7.  Time trends in cancer mortality in China: 1987-1999.

Authors:  Ling Yang; Donald M Parkin; Liandi Li; Yude Chen
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

8.  Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer.

Authors:  Yong Peng; Yuntao Dai; Charles Hitchcock; Xiaojuan Yang; Edmund S Kassis; Lunxu Liu; Zhenghua Luo; Hui-Lung Sun; Ri Cui; Huijun Wei; Taewan Kim; Tae Jin Lee; Young-Jun Jeon; Gerard J Nuovo; Stefano Volinia; Qianchuan He; Jianhua Yu; Patrick Nana-Sinkam; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

9.  miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.

Authors:  Lin Lei; Yaping Huang; Wenrong Gong
Journal:  Oncol Rep       Date:  2013-09-30       Impact factor: 3.906

10.  MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.

Authors:  Xu Qian; Jing Yu; Yu Yin; Jun He; Lin Wang; Qi Li; Lou-Qian Zhang; Chong-Yong Li; Zhu-Mei Shi; Qing Xu; Wei Li; Li-Hui Lai; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Cell Cycle       Date:  2013-04-08       Impact factor: 4.534

View more
  29 in total

1.  miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer.

Authors:  Xiaojie Yu; Yiqiang Zhang; Xiuye Ma; Alexander Pertsemlidis
Journal:  Cancer Lett       Date:  2018-04-13       Impact factor: 8.679

2.  Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.

Authors:  Qiang Zhao; Jun Cao; Yi-Chen Wu; Xiang Liu; Jing Han; Xian-Cong Huang; Lie-Hao Jiang; Xiu-Xiu Hou; Wei-Min Mao; Zhi-Qiang Ling
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma.

Authors:  Jou-Ho Shih; Hsin-Yi Chen; Shin-Chih Lin; Yi-Chen Yeh; Roger Shen; Yaw-Dong Lang; Dung-Chi Wu; Chien-Yu Chen; Ruey-Hwa Chen; Teh-Ying Chou; Yuh-Shan Jou
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

Review 4.  The role of miRNAs in the pheochromocytomas.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-10-13

5.  Grb2-associated binder-2 gene promotes migration of non-small cell lung cancer cells via Akt signaling pathway.

Authors:  Li Jun Xu; Yu Chang Wang; Hong Wen Lan; Jun Li; Tian Xia
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 6.  The role of miRNA regulation in fetal cardiomyocytes, cardiac maturation and the risk of heart disease in adults.

Authors:  Mitchell C Lock; Ross L Tellam; Kimberley J Botting; Kimberley C W Wang; Joseph B Selvanayagam; Doug A Brooks; Mike Seed; Janna L Morrison
Journal:  J Physiol       Date:  2018-06-28       Impact factor: 5.182

7.  MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.

Authors:  Jun Jiang; Xiaojuan Lv; Liang Fan; Guodong Huang; Yan Zhan; Mengyi Wang; Hongda Lu
Journal:  Tumour Biol       Date:  2014-07-11

Review 8.  Insulin Receptor Isoforms in Physiology and Disease: An Updated View.

Authors:  Antonino Belfiore; Roberta Malaguarnera; Veronica Vella; Michael C Lawrence; Laura Sciacca; Francesco Frasca; Andrea Morrione; Riccardo Vigneri
Journal:  Endocr Rev       Date:  2017-10-01       Impact factor: 19.871

9.  Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis.

Authors:  Jinqin Chen; Chengpeng Gao; Wei Zhu
Journal:  Oncol Lett       Date:  2021-05-16       Impact factor: 2.967

10.  Circulating microRNA profile in humans and mice with congenital GH deficiency.

Authors:  Tatiana D Saccon; Augusto Schneider; Cindi G Marinho; Allancer D C Nunes; Sarah Noureddine; Joseph Dhahbi; Yury O Nunez Lopez; Gage LeMunyan; Roberto Salvatori; Carla R P Oliveira; Alécia A Oliveira-Santos; Nicolas Musi; Andrzej Bartke; Manuel H Aguiar-Oliveira; Michal M Masternak
Journal:  Aging Cell       Date:  2021-06-12       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.